Japanese Chemicals Stock News

In recent weeks, Daiichi Sankyo and AstraZeneca secured a major US FDA approval for ENHERTU plus pertuzumab as first-line treatment for unresectable or metastatic HER2-positive breast cancer, while the EMA validated Daiichi Sankyo’s DATROWAY application for first-line use in certain triple negative breast cancer patients based on positive phase 3 data. Together with a new AI-enabled biomarker collaboration and ongoing expansion of ENHERTU into ovarian cancer trials, these moves deepen...

Recently, India's AM Green and Japan's Mitsui & Co. signed a non-binding agreement to explore Mitsui’s potential investment in AM Green’s green aluminium business, including an offtake arrangement for low-carbon aluminium from a planned 1 million tonne smelter and 2 million tonne alumina refinery powered by renewable energy. This early-stage collaboration positions Mitsui directly in the emerging green aluminium value chain, potentially deepening its role in low-carbon materials alongside...

Wondering if Asahi Group Holdings is quietly turning into a value opportunity while everyone is distracted by flashier names? In this overview, we walk through what the market is pricing in and what the fundamentals suggest it might actually be worth. The stock has slipped about 7% over the last week and 6% over the past month, even though it is still up around 1.9% year to date and 1.6% over the last year, with a stronger 27.9% three year and 29.5% five year performance in the...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...

Shareholders appeared unconcerned with Nihon House Holdings Co., Ltd.'s ( TSE:1873 ) lackluster earnings report last...

NS Solutions Corporation ( TSE:2327 ) shareholders have had their patience rewarded with a 26% share price jump in the...

Key Insights West Japan Railway's significant individual investors ownership suggests that the key decisions are...

Sumitomo Realty & Development (TSE:8830) just doubled down on its India pivot by pairing a 2 for 1 stock split with a long term push into Mumbai rentals, especially high end projects in Bandra Kurla Complex. See our latest analysis for Sumitomo Realty & Development. Those shifts are landing against powerful momentum, with a roughly 63 percent year to date share price return and a 70 percent one year total shareholder return suggesting investors are steadily warming to Sumitomo’s second growth...

Kyowa Kirin (TSE:4151) just gave investors a fresh data point to chew on, with new KOMZIFTI combination trial results in acute myeloid leukemia highlighting encouraging activity alongside a clean looking safety profile. See our latest analysis for Kyowa Kirin. Those KOMZIFTI data land as Kyowa Kirin’s 90 day share price return of 7.9% and roughly 9% year to date share price gain suggest sentiment is quietly improving, even though the three year total shareholder return is still in negative...

In a board meeting held on December 16, 2025, Hoshizaki Corporation raised its year-end dividend projection for the fiscal year ending December 2025 from ¥55 to ¥65 per share. This move underlines Hoshizaki’s focus on steady profit distribution and a payout ratio of at least 40% while still funding growth investments and maintaining capital efficiency. We’ll now examine how this higher dividend commitment shapes Hoshizaki’s investment narrative and what it may signal about capital...

Daikin IndustriesLtd (TSE:6367) is pushing deeper into Europe through an expanded joint venture with Copeland, targeting the fast growing residential heat pump market as the region leans harder into its energy transition. See our latest analysis for Daikin IndustriesLtd. Even with this heat pump push in Europe, Daikin’s share price return has only climbed modestly over the year, though a solid 90 day share price return suggests momentum is quietly building as investors warm to its long term...

Wondering if Astellas Pharma’s strong run still offers value, or if you might be late to the party? This breakdown will help you decide whether the current price still makes sense. The stock has climbed 2.2% over the last week, 9.7% in the past month, and is up 37.5% year to date and 43.0% over the last year, so it is firmly on many investors’ radar. Recent headlines have focused on Astellas expanding its pipeline through strategic partnerships and regulatory milestones for key therapies,...

Hino Motors (TSE:7205) just made two strategic calls, selling majority stakes in six domestic sales subsidiaries and backing a SPARX led buyout of key supplier SAWAFUJI ELECTRIC, both tied to its Mitsubishi Fuso integration. See our latest analysis for Hino Motors. Despite the latest restructuring moves, Hino Motors’ recent momentum has been modest. The 90 day share price return is 4.32 percent, while the one year total shareholder return is a much weaker negative 19.55 percent. This signals...

Recent performance and why Sumitomo is back on radar Sumitomo (TSE:8053) has quietly delivered a strong year, with the share price climbing about 70% over the past 12 months and roughly 24% in the past 3 months. See our latest analysis for Sumitomo. That move has been backed by a solid run of buying interest, with a 30 day share price return of just over 15% and a three year total shareholder return above 170%. This suggests momentum is still firmly in Sumitomo’s favour. If Sumitomo’s recent...

SBI Holdings (TSE:8473) has just crystallized value from its banking portfolio by listing subsidiary SBI Shinsei Bank on the Tokyo Stock Exchange Prime Market while cashing in part of its stake for an extraordinary gain. See our latest analysis for SBI Holdings. Those portfolio moves come on top of SBI’s new stake in Indonesia’s Amar Bank and fresh stock option plans for employees, and the market has taken notice, with a roughly 65 percent year to date share price return and a striking multi...

DENSO Corporation ( TSE:6902 ) will pay a dividend of ¥32.00 on the 27th of May. This means the dividend yield will be...

On December 9, 2025, AGC Inc. announced wide‑ranging governance moves, including the upcoming resignation of CFO Shinji Miyaji and multiple board and audit & supervisory board departures effective March 27, 2026, alongside a planned shift to a Company with Audit and Supervisory Committee structure, subject to shareholder approval in March 2026. This combination of leadership turnover and a board structure change signals a meaningful reset of how AGC will oversee risk, capital allocation and...

Mitsubishi Electric (TSE:6503) just unveiled AI powered in vehicle tech designed to spot driver intoxication from pulse and driving behavior, a move that puts its automotive safety ambitions firmly in the spotlight. See our latest analysis for Mitsubishi Electric. The announcement caps a busy run of AI and sustainability updates, and the market seems to like the direction, with a roughly 71 percent year to date share price return and a near 80 percent one year total shareholder return...

Nintendo (TSE:7974) is in the spotlight after higher memory chip costs pressured margins just as its Switch 2 console takes off, a timing twist that is reshaping how investors think about its next hardware cycle. See our latest analysis for Nintendo. The recent drop, including a 1 month share price return of negative 18.27 percent, likely reflects investors recalibrating near term margin expectations, even as Nintendo’s 3 year total shareholder return of 103.06 percent suggests the longer...

Rigaku Holdings Corporation ( TSE:268A ) shareholders have had their patience rewarded with a 29% share price jump in...

Nippon Steel Corporation ( TSE:5401 ) is reducing its dividend from last year's comparable payment to ¥12.00 on the...

Board moves to retire shares Kubota (TSE:6326) has kicked off December with a board meeting focused on retiring a portion of its common stock under Japan’s Companies Act, a textbook move to tighten the share count and support long term value. See our latest analysis for Kubota. That decision lands against a strong backdrop, with Kubota’s 1 month share price return of 13.87 percent and 3 month share price return of 23.16 percent pointing to building momentum, while a 1 year total shareholder...

On December 15, 2025, Sumitomo Realty & Development’s board approved plans to introduce a first-of-its-kind trust scheme in Japan to systematically sell the listed securities the company holds. This move highlights a shift in how the company manages its investment portfolio, with potential implications for capital allocation priorities and balance-sheet composition. We’ll now look at how this trust-based, systematic sale of listed securities could reshape Sumitomo Realty & Development’s...

In mid-December 2025, Takeda reported positive topline data from two pivotal Phase 3 trials of its next‑generation oral TYK2 inhibitor zasocitinib in adults with moderate‑to‑severe plaque psoriasis, showing superiority to placebo and an active comparator on key skin‑clearance endpoints. Because zasocitinib is a once‑daily oral pill that achieved high rates of near‑complete and complete skin clearance, it could reshape treatment options in plaque psoriasis if successfully approved. We’ll now...